Financial Consulate’s Phibro Animal Health PAHC Stock Holding History

Financial Consulate’s Portfolio PAHC Stock Details PAHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$72	Buy	+2	New	+$70	﹤0.01%	1842

Other funds holding PAHC

Cardinal Capital Management Inc (North Carolina) Raleigh, North Carolina $861M AUM 27.19% 1-Year Est. Return

SummerHaven Investment Management Stamford, Connecticut $179M AUM 57.61% 1-Year Est. Return

Harbor Capital Advisors Chicago, Illinois $1.48B AUM 30.88% 1-Year Est. Return

Kings Path Partners Sugar Land, Texas $380M AUM 12.42% 1-Year Est. Return

Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return

Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.56B AUM 41.43% 1-Year Est. Return

Atria Investments Charlotte, North Carolina $10.3B AUM 19.62% 1-Year Est. Return

Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return

Balboa Wealth Partners Scottsdale, Arizona $748M AUM 37.86% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Financial Consulate's PAHC Position: Q3 2026 in Review

Financial Consulate opened a new position in Phibro Animal Health (PAHC) in Q3 2026: 2 shares worth $72. The stake represents ﹤0.01% of the portfolio and ranks #1842 among its holdings.

32 funds tracked by Wall St. Rank hold PAHC as of Q3 2026.

Financial Consulate held 2 shares of Phibro Animal Health worth $72 as of Q3 2026.
Phibro Animal Health was a new Financial Consulate position in Q3 2026.
Phibro Animal Health made up ﹤0.01% of Financial Consulate's portfolio in Q3 2026, its #1842 holding.
32 funds tracked by Wall St. Rank held Phibro Animal Health as of Q3 2026.

Based on Financial Consulate's 13F filing for Q3 2026, filed 23 Oct 2026.